Evidence map›Paper›PMID 38904390›Full record

ArticleAntimicrobial agents and chemotherapy2024

Applying whole genome sequencing to predict phenotypic drug resistance in

Mads Lindholm Kurtzhals, Anders Norman, Erik Svensson, Troels Lillebaek, Dorte Bek Folkvardsen

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mads Lindholm KurtzhalsInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0009-0003-4006-9950
Anders NormanInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-1282-394X
Erik SvenssonInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0003-0797-1080
Troels Lillebaek *International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-2601-2718
Dorte Bek Folkvardsen *International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-6430-4586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with

Indexed as

Antitubercular AgentsMicrobial Sensitivity TestsMycobacterium tuberculosisWhole Genome SequencingDenmarkDrug Resistance, Multiple, BacterialEthambutolGenome, BacterialHumansIsoniazidMutationPyrazinamideRifampinTuberculosis, Multidrug-ResistantAntitubercular AgentsEthambutolIsoniazidPyrazinamideRifampinresistancetuberculosiswhole genome sequencing

Identifiers

PMID38904390
PMCPMC11304686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.